Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
Tobias JD, Berkenbosch JW
Clin Pediatr (Phila) 2002;41(8):613-616.
NATA Rating :
Review by : Aldouri M
This is a case report on a successful use of recombinant factor VIIa in treating hematemesis in an 11-month-old infant who suffered with esophageal varices, hepatic dysfunction and previous necrotizing enterocolitis. Prior treatment with platelets, FFP and octreotide did not succeed in controlling the bleeding.
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.